Professor, The University of Sydney
| Role | Organisation | Sources |
|---|---|---|
| Professor | The University of Sydney | Startup Daily, GBS Ventures |
Stories naming Professor Tony Weiss. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Anniversary profile of incubator Cicada Innovations' two decades, telling portfolio biotech Elastagen's story: its tropoelastin work, Series A backing, a government grant, and its 2018 sale to Allergan.
Also GBS Ventures·GBS Ventures
Cell Innovation Partners invested A$1 million in Sydney biotech Elastagen within a second close of its A$14 million Series B, with AMOREPACIFIC Ventures, Korea Investment Partners and the Wellcome Trust also joining the round.